NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease

Among patients with Parkinson’s disease (PD), depression is prevalent and disabling, impacting both health outcomes and quality of life. There is a critical need for alternative pharmacological methods to treat PD depression, as mainstream antidepressant drugs are largely ineffective in this populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanle, Brigitte, Olcott, William, Jimenez, Jaime, Bashmi, Luma, Danovitch, Itai, IsHak, Waguih William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003962/
https://www.ncbi.nlm.nih.gov/pubmed/29907742
http://dx.doi.org/10.1038/s41398-018-0162-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003962/
https://www.ncbi.nlm.nih.gov/pubmed/29907742
http://dx.doi.org/10.1038/s41398-018-0162-2

Ejemplares similares